Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles.
about
Endometriosis: where are we and where are we going?Endometriosis and ovarian cancer: links, risks, and challenges facedAn Immunohistochemical Algorithm for Ovarian Carcinoma Typing.The significance of markers in the diagnosis of endometrial cancerNew classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical careStructural mutation analysis of PTEN and its genotype-phenotype correlations in endometriosis and cancerRoles of deletion of Arid1a, a tumor suppressor, in mouse ovarian tumorigenesisPTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer.The promise and challenge of ovarian cancer models.Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing - a case report.Arid1a inactivation in an Apc- and Pten-defective mouse ovarian cancer model enhances epithelial differentiation and prolongs survival.Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas.Genetic and molecular changes in ovarian cancer.ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas.Understanding Molecular Landscape of Endometrial Cancer through Next Generation Sequencing: What We Have Learned so Far?Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma.Role of Wnt/β-catenin, Wnt/c-Jun N-terminal kinase and Wnt/Ca2+ pathways in cisplatin-induced chemoresistance in ovarian cancer.Ovarian cancer in endometriosis: clinical and molecular aspects.Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian Cancer.Association of Hormone Receptor Expression with Survival in Ovarian Endometrioid Carcinoma: Biological Validation and Clinical Implications.The emerging roles of ARID1A in tumor suppression.Novel insights on the malignant transformation of endometriosis into ovarian carcinoma.Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer.Immunohistochemical characterization of endometrial carcinomas: endometrioid, serous and clear cell adenocarcinomas in association with genetic analysis.The role of microRNAs in the pathogenesis of endometrial cancer: a systematic review.Mutational heterogeneity in non-serous ovarian cancers.Progression inference for somatic mutations in cancer.The changing landscape of gynaecological cancer diagnosis: implications for histopathological practice in the 21st century.Prediction of therapy response in ovarian cancer: Where are we now?Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.Effects of Endocrine-Disrupting Chemicals and Epigenetic Modifications in Ovarian Cancer: A Review.Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. nurses.Impact of oviductal versus ovarian epithelial cell of origin on ovarian endometrioid carcinoma phenotype in the mouse.Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups.Low Arid1a Expression Correlates with Poor Prognosis and Promotes Cell Proliferation and Metastasis in Osteosarcoma.Genotyping and mRNA profiling reveal actionable molecular targets in biliary tract cancers.Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality.Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden.Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression.Unraveling endometriosis-associated ovarian carcinomas using integrative proteomics.
P2860
Q26750772-3FCB86EC-ADF6-4DCB-ADD0-4915E6AB414EQ27003273-AB6E59B6-ED20-42EB-9FD6-07F64D20A38BQ27313766-4A51E7F6-F03A-44E7-B90A-812FC279F5FEQ28067066-4C3794C3-3770-45F2-805C-73586392B161Q28078792-599B118A-8DBE-46D2-AA06-3FD8A7C166CAQ30391301-7B642BD2-B4C0-4B90-82EC-D1155F22DD37Q33752609-AE17420E-4CCD-4D67-9343-EBB061230A66Q35691011-CDC0B8DC-EBB5-4E1A-A2FF-A423F7D16A0EQ35771750-9C9314D5-63AB-4F37-89AB-F1D3BEAC0A1DQ36254394-464DD823-E761-481A-B354-182EF4D32E97Q36469778-84CD50E6-3A4A-488C-8531-A4079BD558C6Q37007851-134F6C0C-C310-4501-8597-832CB0B58E95Q37094076-14BC9D83-3515-4B51-B0CC-F374F9995A63Q37225222-97B12BE5-EDD1-4370-BAF3-43980788E5F4Q37382351-0703B82A-A725-4C54-9F13-74463A1F1B5BQ37388203-36B7955E-827C-4BED-9795-4634FA8C33F3Q37582011-91A28BA2-A68E-4A0B-893C-C9244326321CQ37645709-F79065F0-4CAA-4679-B6C1-67AC9613347CQ37723027-AA2C5E94-DB94-4D74-BFA9-A80695A74B4EQ37729055-8E074FEA-39D3-458C-A306-0FD621512415Q38195175-A0E43F27-6E37-459F-91B4-297D8EB2F786Q38218228-6CEF59B3-DABF-4A50-9947-2713F7754C4BQ38242086-503D7B0C-DAE0-47C0-A190-C9305EC76A39Q38264390-3CDAD9E8-56A8-4CF4-8715-6D74014ECBA8Q38362213-AD1AA896-C423-4C15-992C-47BAB179E9EDQ38602953-E78643C0-F167-4299-A928-6B800CEAC0BCQ38793244-563EE037-F556-4574-8E83-E20113577C29Q39037647-98CFDF79-0AFC-43DE-A1CF-97621668B26EQ39263260-E11D1768-594A-4C5D-802E-18B98D6A4037Q39345895-89F34313-031A-44A4-A0FE-2B5846B3E0D3Q39364797-88C94BE1-8924-4F29-8ACD-1085EB5A9440Q40290088-67C271B3-766B-48D8-90DA-1C9FEF3E2C51Q42671513-00C5DFC3-17E2-4D3F-9B1E-79560736B8A2Q46364204-6E452ABD-987A-4F9D-B9D4-3E401F03A354Q47362802-4AB9BAEC-67B0-432B-B1C8-B29B5930547BQ50127508-9683610C-C1A6-4DB5-A33D-330DE1504D2FQ52886475-52B07DCB-B52D-480E-8787-958359DEF2EBQ54289649-394FFE28-4C51-42CD-9098-538421F482A2Q54324522-09A42387-4220-4453-AFC2-E50E92109158Q55256135-1FDE4C8A-A16A-4FBD-9299-6DDC2442E771
P2860
Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Ovarian and endometrial endome ...... B1 and PTEN mutation profiles.
@ast
Ovarian and endometrial endome ...... B1 and PTEN mutation profiles.
@en
Ovarian and endometrial endome ...... B1 and PTEN mutation profiles.
@nl
type
label
Ovarian and endometrial endome ...... B1 and PTEN mutation profiles.
@ast
Ovarian and endometrial endome ...... B1 and PTEN mutation profiles.
@en
Ovarian and endometrial endome ...... B1 and PTEN mutation profiles.
@nl
prefLabel
Ovarian and endometrial endome ...... B1 and PTEN mutation profiles.
@ast
Ovarian and endometrial endome ...... B1 and PTEN mutation profiles.
@en
Ovarian and endometrial endome ...... B1 and PTEN mutation profiles.
@nl
P2093
P2860
P1433
P1476
Ovarian and endometrial endome ...... B1 and PTEN mutation profiles.
@en
P2093
Alicia A Tone
C Blake Gilks
Cheng-Han Lee
David G Huntsman
Janine Senz
Jessica N McAlpine
Jiarui Ding
Kimberly C Wiegand
Leah M Prentice
Melissa K McConechy
P2860
P2888
P304
P356
10.1038/MODPATHOL.2013.107
P577
2013-06-14T00:00:00Z
P5875
P6179
1026225969